Evidence map›Paper›PMID 21270409›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2011

Anaphylaxis and mortality induced by treatment of mice with anti-VLA-4 antibody and pertussis toxin.

Niannian Ji, Nagarjun Rao, Neal M Guentzel, Bernard P Arulanandam, Thomas G Forsthuber

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Niannian JiDepartment of Biology, University of Texas at San Antonio, San Antonio, TX 78249, USA.
Nagarjun Rao
Neal M Guentzel
Bernard P Arulanandam
Thomas G Forsthuber
The University of Texas at San Antonio · USMedical College of Wisconsin · US

Funding

Steroid resistance: Experimental Autoimmune Encephalomyelitis/Multiple SclerosisR01NS052177 · NINDS · UNIVERSITY OF TEXAS SAN ANTONIO · PI FORSTHUBER, THOMAS G. · 2007 to 2010
$1.2M
NINDS NIH HHS NS-52177NINDS NIH HHS R01 NS052177
6 · The paper itself

Abstract

Ab-mediated blockade of the adhesion molecule VLA-4 has been shown to ameliorate disease in human multiple sclerosis patients and experimental autoimmune encephalomyelitis (EAE) animal models. We wanted to determine whether anti-VLA-4 Ab treatment affected the function and persistence of autoreactive T cells in mice with EAE. Unexpectedly, we observed a high level of mortality in anti-VLA-4 mAb (PS/2)-treated mice with actively induced EAE despite decreased disease severity. Investigation of the underlying mechanism showed that injection of PS/2 mAb in combination with pertussis toxin resulted in anaphylaxis and mortality. Furthermore, the data showed that CD4(+) T cells were required for this effect and suggested a role for IL-1β and TNF-α in the underlying pathology. The results reveal a previously not appreciated deleterious effect of anti-VLA-4 Ab treatment in combination with exposure to pertussis toxin.

Indexed as

AnaphylaxisAnimalsAntibodies, BlockingAntibodies, MonoclonalDrug CombinationsEncephalomyelitis, Autoimmune, ExperimentalFemaleIntegrin alpha4beta1MiceMice, Inbred C57BLMice, KnockoutMice, SCIDMyelin-Associated GlycoproteinMyelin-Oligodendrocyte GlycoproteinMyelin ProteinsPertussis ToxinAntibodies, BlockingAntibodies, MonoclonalDrug CombinationsIntegrin alpha4beta1MOG protein, humanMog protein, mouseMyelin-Associated GlycoproteinMyelin-Oligodendrocyte GlycoproteinMyelin ProteinsPertussis ToxinTumor Necrosis Factor-alpha

Identifiers

PMID21270409
PMCPMC4064569
OpenAlexW2115028692

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.